oxandrolone has been researched along with Acute Liver Injury, Drug-Induced in 11 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mortality, infection, and hepatic function: Oxandrolone therapy did not affect mortality (relative risk (RR)=0." | 8.93 | The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis. ( Guo, Q; Guo, Y; Li, H; Roy, M; Yang, Z, 2016) |
| " Mortality, infection, and hepatic function: Oxandrolone therapy did not affect mortality (relative risk (RR)=0." | 4.93 | The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis. ( Guo, Q; Guo, Y; Li, H; Roy, M; Yang, Z, 2016) |
| "Oxandrolone has proven benefits in thermal burn injury and has become a standard of care." | 1.51 | Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients. ( Foster, CJ; Gayed, RM; Hill, DM; Jones, KM; Kiracofe, B; Murphy, CV; Oltrogge Pape, K; Porter, K; Reger, M; Zavala, S, 2019) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fourches, D | 1 |
| Barnes, JC | 1 |
| Day, NC | 1 |
| Bradley, P | 1 |
| Reed, JZ | 1 |
| Tropsha, A | 1 |
| Chen, M | 2 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 3 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Kiracofe, B | 2 |
| Coffey, R | 1 |
| Jones, LM | 1 |
| Bailey, JK | 1 |
| Thomas, S | 1 |
| Porter, K | 2 |
| Murphy, CV | 2 |
| Zavala, S | 1 |
| Gayed, RM | 1 |
| Foster, CJ | 1 |
| Jones, KM | 1 |
| Oltrogge Pape, K | 1 |
| Hill, DM | 1 |
| Reger, M | 1 |
| Li, H | 1 |
| Guo, Y | 1 |
| Yang, Z | 1 |
| Roy, M | 1 |
| Guo, Q | 1 |
| Segal, S | 1 |
| Cooper, J | 1 |
| Bolognia, J | 1 |
| Jackson, ST | 1 |
| Rallison, ML | 1 |
| Buntin, WH | 1 |
| Johnson, SB | 1 |
| Flynn, RR | 1 |
| Sansoy, OM | 1 |
| Roy, AN | 1 |
| Shields, LM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients[NCT03678233] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-06-27 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxandrolone and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis.
Topics: Anabolic Agents; Body Composition; Body Weight; Burns; Chemical and Drug Induced Liver Injury; Human | 2016 |
9 other studies available for oxandrolone and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anabolic Agents; Aspartate Aminotransferases; Bil | 2019 |
Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients.
Topics: Adult; Age Factors; Anabolic Agents; Burns; Chemical and Drug Induced Liver Injury; Female; Humans; | 2019 |
Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity.
Topics: Anabolic Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Hyperpigmentation; Middle A | 2000 |
Use of oxandrolone for growth stimulation in children.
Topics: Administration, Oral; Adolescent; Age Determination by Skeleton; Age Factors; Body Height; Bone Deve | 1973 |
Anabolic action and side effects of oxandrolone in 34 mental patients.
Topics: Adult; Age Factors; Aged; Arthritis; Aspartate Aminotransferases; Blood Chemical Analysis; Body Weig | 1971 |
Androgenic and anabolic hormones.
Topics: Anabolic Agents; Androgens; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Ethyles | 1966 |